Skip to main content

CORRECTION article

Front. Toxicol., 25 March 2024
Sec. In Vitro Toxicology
Volume 6 - 2024 | https://doi.org/10.3389/ftox.2024.1394396
This article is part of the Research Topic European Partnership on the Assessment of Risks from Chemicals (PARC): Focus on New Approach Methodologies (NAMs) in Risk Assessment View all 9 articles

Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project

Albert Braeuning Albert Braeuning1*Patrick BalaguerPatrick Balaguer2William BourguetWilliam Bourguet3Jordi Carreras-PuigvertJordi Carreras-Puigvert4Katreece FeiertagKatreece Feiertag5Jorke H. KamstraJorke H. Kamstra6Dries KnapenDries Knapen7Dajana LichtensteinDajana Lichtenstein1Philip Marx-StoeltingPhilip Marx-Stoelting5Jonne RietdijkJonne Rietdijk4Kristin SchubertKristin Schubert8Ola SpjuthOla Spjuth4Evelyn StinckensEvelyn Stinckens7Kathrin ThedieckKathrin Thedieck9Rik van den BoomRik van den Boom7Lucia VergauwenLucia Vergauwen7Martin von BergenMartin von Bergen8Neele WewerNeele Wewer1Daniel ZalkoDaniel Zalko10
  • 1Department of Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany
  • 2IRCM (Institut de Recherche en Cancérologie de Montpellier), Inserm U1194, Université de Montpellier, ICM, Montpellier, France
  • 3CBS Centre de Biologie Structurale, Université de Montpellier, CNRS, Inserm, Montpellier, France
  • 4Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
  • 5Department of Pesticides Safety, German Federal Institute for Risk Assessment, Berlin, Germany
  • 6Department of Population Health Sciences, Institute for Risk Assessment Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands
  • 7Zebrafishlab, Veterinary Physiology and Biochemistry, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium
  • 8Department of Molecular Systems Biology, Helmholtz Centre for Environmental Research (UFZ), Leipzig, Germany
  • 9Institute of Biochemistry and Center for Molecular Biosciences Innsbruck, University of Innsbruck, Innsbruck, Austria
  • 10Toxalim (Research Centre in Food Toxicology), Université de Toulouse, Institut National de Recherche Pour L’Agriculture, L’Alimentation et L’Environnement (INARE), Ecole Nationale Vétérinaire de Toulouse (ENVT), INP-Purpan, Université Paul Sabatier (UPS), Toulouse, France

A Corrigendum on
Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project

by Braeuning A, Balaguer P, Bourguet W, Carreras-Puigvert J, Feiertag K, Kamstra JH, Knapen D, Lichtenstein D, Marx-Stoelting P, Rietdijk J, Schubert K, Spjuth O, Stinckens E, Thedieck K, van den Boom R, Vergauwen L, von Bergen M, Wewer N and Zalko D (2023). Front. Toxicol. 5:1212509. doi: 10.3389/ftox.2023.1212509

In the published article, there was an error. In Section 5 an erroneous entry was introduced, indicating an opposite effect of what was shown in the reference referring to that entry.

A correction has been made to ‘5 Measures for obesogenic effects of MDCs’, paragraph 2. This sentence previously started:

“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives attenuated adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”

The corrected sentence appears below:

“In contrast, in human bone marrow-derived mesenchymal stem cells (hMSCs), BPA alternatives induced adipogenesis (Norgren et al., 2022), stressing the importance to research mechanisms and variable exposure scenarios.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: endocrine metabolic disruption, energy metabolism, obesogens, nuclear receptors, adipocytes, liver

Citation: Braeuning A, Balaguer P, Bourguet W, Carreras-Puigvert J, Feiertag K, Kamstra JH, Knapen D, Lichtenstein D, Marx-Stoelting P, Rietdijk J, Schubert K, Spjuth O, Stinckens E, Thedieck K, van den Boom R, Vergauwen L, von Bergen M, Wewer N and Zalko D (2024) Corrigendum: Development of new approach methods for the identification and characterization of endocrine metabolic disruptors—a PARC project. Front. Toxicol. 6:1394396. doi: 10.3389/ftox.2024.1394396

Received: 01 March 2024; Accepted: 15 March 2024;
Published: 25 March 2024.

Edited and reviewed by:

Bengt Fadeel, Karolinska Institutet (KI), Sweden

Copyright © 2024 Braeuning, Balaguer, Bourguet, Carreras-Puigvert, Feiertag, Kamstra, Knapen, Lichtenstein, Marx-Stoelting, Rietdijk, Schubert, Spjuth, Stinckens, Thedieck, van den Boom, Vergauwen, von Bergen, Wewer and Zalko. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Albert Braeuning, albert.braeuning@bfr.bund.de

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.